We are live on ! Find out more
OGC

Oak Grove Capital Portfolio holdings

AUM $1.18B
1-Year Est. Return 84.79%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+84.79%
3 Year Est. Return
+236.05%
5 Year Est. Return
+282.98%
10 Year Est. Return
AUM
$199M
AUM Growth
-$97.2M
Cap. Flow
-$125M
Cap. Flow %
-62.75%
Top 10 Hldgs %
67.46%
Holding
63
New
8
Increased
5
Reduced
38
Closed
9

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.8M
2
LRCX icon
Lam Research
LRCX
+$9.08M
3
NVDA icon
NVIDIA
NVDA
+$8.27M
4
CRWD icon
CrowdStrike
CRWD
+$8.15M
5
ABBV icon
AbbVie
ABBV
+$6.53M

Sector Composition

Rank Sector Weight
1 Technology 39.45%
2 Healthcare 19.92%
3 Financials 12.41%
4 Consumer Staples 8.85%
5 Energy 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$31.3M 15.74%
241,128
-24,505
-9% -$3.5M
COST icon
2
Costco
COST
$415B
$17.6M 8.85%
38,596
-3,150
-8% -$1.54M
AMD icon
3
Advanced Micro Devices
AMD
$851B
$16.7M 8.4%
258,076
-300,492
-54% -$19.8M
BN icon
4
Brookfield
BN
$102B
$16.6M 8.33%
790,302
-219,122
-22% -$4.91M
ABBV icon
5
AbbVie
ABBV
$458B
$11.7M 5.87%
72,248
-42,593
-37% -$6.53M
LLY icon
6
Eli Lilly
LLY
$1.07T
$9.91M 4.98%
27,075
+14,575
+117% +$5.17M
NVO
7
Novo Nordisk
NVO
$216B
$9.07M 4.56%
134,040
+108,442
+424% +$6.36M
KMI icon
8
Kinder Morgan
KMI
$73.1B
$7.57M 3.8%
418,579
-154,815
-27% -$2.78M
SPY icon
9
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$7.18M 3.61%
242,000
-41,100
-15% -$15.8M
EQNR icon
10
Equinor
EQNR
$95.9B
$6.64M 3.33%
+185,311
New +$6.65M
INDI icon
11
indie Semiconductor
INDI
$733M
$6.58M 3.31%
1,129,371
-354,699
-24% -$2.62M
COHR icon
12
Coherent
COHR
$55.2B
$5.73M 2.88%
163,162
-170,170
-51% -$5.92M
TMO icon
13
Thermo Fisher Scientific
TMO
$211B
$5.69M 2.86%
10,327
-1,525
-13% -$808K
MRVL icon
14
Marvell Technology
MRVL
$174B
$4.61M 2.32%
124,429
-136,445
-52% -$5.57M
MSFT icon
15
Microsoft
MSFT
$2.84T
$3.96M 1.99%
16,528
-20,256
-55% -$4.86M
BAM icon
16
Brookfield Asset Management
BAM
$74B
$3.85M 1.94%
+134,415
New +$4.04M
CRWD icon
17
CrowdStrike
CRWD
$187B
$3.34M 1.68%
126,944
-238,096
-65% -$8.15M
RH icon
18
RH
RH
$3.3B
$3.18M 1.6%
11,896
-12,218
-51% -$3.18M
BRK.A icon
19
Berkshire Hathaway Class A
BRK.A
$1.07T
$2.34M 1.18%
5
NVDA icon
20
NVIDIA
NVDA
$5.01T
$2.07M 1.04%
141,600
-563,740
-80% -$8.27M
DHR icon
21
Danaher
DHR
$135B
$2.03M 1.02%
8,644
-24,516
-74% -$5.68M
HON icon
22
Honeywell
HON
$77.1B
$1.79M 0.9%
8,863
-20,567
-70% -$3.93M
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.7M 0.85%
5,509
-4,912
-47% -$1.46M
LRCX icon
24
Lam Research
LRCX
$382B
$1.59M 0.8%
37,940
-217,060
-85% -$9.08M
AAPL icon
25
CALL
Apple
AAPL
$4.89T
$1.48M 0.74%
52,100
-24,800
-32% -$3.54M

Similar funds

Oak Grove Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Oak Grove Capital held 63 positions worth $199M, down 33% from $296M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Oak Grove Capital withdrew a net $125M in Q4 2022, closing 9 positions and reducing 38 holdings. Its most notable exit was Freeport-McMoran, an estimated $1.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 53% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oak Grove Capital opened a new position in Equinor worth $6.64M.

  • Oak Grove Capital's largest Q4 2022 buy was Equinor: 185,311 shares worth $6.64M.
  • Oak Grove Capital added most to Novo Nordisk in Q4 2022, an estimated $6.36M increase.
  • Oak Grove Capital's biggest Q4 2022 reduction was Advanced Micro Devices, cutting an estimated $19.8M.
  • Oak Grove Capital fully exited Freeport-McMoran in Q4 2022, selling an estimated $1.41M.
  • Oak Grove Capital's ten largest holdings make up 67% of its $199M portfolio in Q4 2022.
  • Oak Grove Capital opened 8 new positions and closed 9 in Q4 2022.
  • Oak Grove Capital's portfolio value fell 33% quarter-over-quarter to $199M.

Based on Oak Grove Capital's 13F filing for Q4 2022, filed 8 Feb 2023.